The projected mortality from bladder malignant neoplasms in the UK demonstrates a gradual upward trend from 5.83 thousand deaths in 2024 to 6.0 thousand by 2028. Comparing year-on-year variations indicates minimal increases annually: 0.69% from 2024 to 2025, 0.85% from 2025 to 2026, 0.68% from 2026 to 2027, and 0.67% from 2027 to 2028. For context, the value in 2023 was slightly below 5.83 thousand. The compound annual growth rate (CAGR) over the forecast period is approximately 0.82%, reflecting a modest but consistent annual increase in mortality rates.

Future trends to monitor include:

Advancements in medical treatments and early detection, potentially influencing mortality rates.
Changes in healthcare policy and funding affecting cancer research and patient care.
Demographic shifts and aging population, which may impact incidence and mortality rates.